Catalyst Wire Dossier Catalyst Wire Dossier

Quemliclustat

Quemliclustat · Arcus Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Quemliclustat, covering 2026-01-15 to 2026-06-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]

See pricing